Literature DB >> 31346990

Dynamic Variation of RAS on Silicotic Fibrosis Pathogenesis in Rats.

Bo-Nan Zhang1,2,3, Xin Zhang2, Hong Xu2, Xue-Min Gao4, Gui-Zhen Zhang2, Hui Zhang2, Fang Yang5.   

Abstract

The dynamic variation of renin-angiotensin system (RAS) in silicosis remains unclear. Seventy Wistar rats were divided into 7 groups including control group, silicosis groups (inhaling SiO2 for 2, 4, 8, 16 and 24 weeks, respectively) and Captopril (Cap) group. Rat lung primary fibroblasts were divided into control group, SiO2-stimulated group (0, 0.5, 1, 3, 6, 12, 24 and 48 h) and Cap group. The silicotic nodules were formed and collagens were deposited gradually in silicosis group observed by haematoxylin and eosin (HE) staining and Van Gieson (VG) staining. Cap relieved the lung fibrosis and collagen deposition. Immunohistochemistry indicated the positive expression of α-smooth muscle actin (α-SMA) was increased gradually in silicotic rat lung tissue. Western blotting revealed the expression of collagen type I (Col I) and α-SMA was up-regulated in silicotic rat lung tissue and fibroblasts stimulated by SiO2. Cap decreased the expression of Col I and α-SMA in silicotic rat lung tissue and fibroblasts stimulated by SiO2. Western blotting also demonstrated the expression of angiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor (AT1) was increased, and the expression of ACE2 and Mas was decreased gradually in silicotic rat lung tissue and fibroblasts stimulated by SiO2. ELISA showed the serum levels of ACE and angiotensin II (Ang II) were also increased and ACE2 and Ang (1-7) were decreased in the silicosis group. Treatment with Cap decreased the expression levels of ACE, Ang II and AT1, and increased the expression levels of ACE2, Ang (1-7) and Mas. These findings suggested that an imbalance between ACE-Ang II-AT1 axis and ACE2-Ang (1-7)-Mas axis may participate in the development of silicosis.

Entities:  

Keywords:  SiO2; fibroblasts; renin-angiotensin system; silicosis; α-smooth muscle actin

Mesh:

Substances:

Year:  2019        PMID: 31346990     DOI: 10.1007/s11596-019-2073-8

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  33 in total

1.  Accelerated silicosis in workers exposed to agate dust in Guangzhou, China.

Authors:  C Q Jiang; L W Xiao; T H Lam; N W Xie; C Q Zhu
Journal:  Am J Ind Med       Date:  2001-07       Impact factor: 2.214

2.  Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis.

Authors:  C Grönhagen-Riska; K Kurppa; F Fyhrquist; O Selroos
Journal:  Scand J Respir Dis       Date:  1978-08

Review 3.  Renin-angiotensin system blockade: Its contribution and controversy.

Authors:  Akira Miyajima; Takeo Kosaka; Eiji Kikuchi; Mototsugu Oya
Journal:  Int J Urol       Date:  2015-05-29       Impact factor: 3.369

4.  Effect of bone morphogenic protein-7 on the expression of epithelial-mesenchymal transition markers in silicosis model.

Authors:  Yan Wang; Gengxia Yang; Zhonghui Zhu; Di Liang; Piye Niu; Ai Gao; Li Chen; Lin Tian
Journal:  Exp Mol Pathol       Date:  2015-03-12       Impact factor: 3.362

Review 5.  Basic pathogenetic mechanisms in silicosis: current understanding.

Authors:  Binaya Rimal; Alissa K Greenberg; William N Rom
Journal:  Curr Opin Pulm Med       Date:  2005-03       Impact factor: 3.155

Review 6.  Renin-angiotensin system in the pathogenesis of liver fibrosis.

Authors:  Regina Maria Pereira; Robson Augusto Souza dos Santos; Filipi Leles da Costa Dias; Mauro Martins Teixeira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

7.  Angiogenic activity of sera from interstitial lung disease patients in relation to angiotensin-converting enzyme activity.

Authors:  T M Zielonka; K Zycinska; J Chorostowska-Wynimko; M Filewska; B Bialas; M H Obrowski; E Radzikowska; E Skopinska-Rozewska; U Demkow
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats.

Authors:  Ali A Hemmati; Zahra Nazari; Mehdi Samei
Journal:  Pulm Pharmacol Ther       Date:  2008-05-03       Impact factor: 3.410

9.  Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.

Authors:  Kathleen E Tumelty; Barbara D Smith; Matthew A Nugent; Matthew D Layne
Journal:  J Biol Chem       Date:  2013-12-16       Impact factor: 5.157

10.  Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis.

Authors:  Yan Liu; Hong Xu; Yucong Geng; Dingjie Xu; Lijuan Zhang; Yi Yang; Zhongqiu Wei; Bonan Zhang; Shifeng Li; Xuemin Gao; Ruimin Wang; Xianghong Zhang; Darrell Brann; Fang Yang
Journal:  Respir Res       Date:  2017-02-21
View more
  4 in total

Review 1.  Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.

Authors:  Murat Oz; Dietrich Ernst Lorke
Journal:  Biomed Pharmacother       Date:  2021-01-05       Impact factor: 6.529

2.  Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.

Authors:  Hisashi Kai; Mamiko Kai; Hiroshi Niiyama; Norihito Okina; Motoki Sasaki; Takanobu Maeda; Atsushi Katoh
Journal:  Hypertens Res       Date:  2021-03-10       Impact factor: 3.872

3.  Silica Induction of Diverse Inflammatory Proteome in Lungs of Lupus-Prone Mice Quelled by Dietary Docosahexaenoic Acid Supplementation.

Authors:  Lichchavi D Rajasinghe; Melissa A Bates; Abby D Benninghoff; Kathryn A Wierenga; Jack R Harkema; James J Pestka
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

4.  Pathological Comparison of Rat Pulmonary Models Induced by Silica Nanoparticles and Indium-Tin Oxide Nanoparticles.

Authors:  Yi Guan; Nan Liu; Yan Yu; Qiang Zhou; Meiyu Chang; Yongheng Wang; Sanqiao Yao
Journal:  Int J Nanomedicine       Date:  2022-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.